U.S. Patent Office grants Artificial Intelligence startup CREOpoint IP to help stop the spread of fake news on social media

American-European Entrepreneurs unveil licensable intellectual property for Big Tech and others to regain trust, improve health and save democracy.

Click on links under logos to access the patents

“CREOpoint is one of the few companies providing patented solutions for filtering out undesirable or misleading social media information” said Schwegman IP Attorney Michael Dunnam, former chair of the Electronic and Computer Law Committee of the American Intellectual Property Law Association.

“There has been little patent activity in this space, which suggests that R&D is surprisingly limited. Pioneering and focused companies like CREOpoint can lead the way by providing information overload controls which allow users to contain the spread of misinformation and disinformation."

Goldenstein founded and funded CREOpoint with support from an eclectic team of lifelong friends leaders in media, tech, financial and professional services. The genesis of CREOpoint’s latest IP efforts was the recognition that humanity can’t reliably know what’s real, placing truth and democracy at risk. 

Even though they have trillions of dollars in combined market caps, a small number of giant American digital media companies have received fewer than a dozen U.S. patents related to containing the daily wildfire of "fake news" and time-wasting digital addiction. That includes Apple, Facebook, Google, IBM, Microsoft, Snap and Twitter.

Calling innovators to the rescue to save trust

Given the exploding powers of weaponized private data on a darker web, we at CREOpoint are compelled to defend society’s collective moral compass by listening and gathering other concerned citizens and ethical technologists. CREOpoint seeks to partner with people who see the power of our inventions to improve people’s lives, mitigate reputational damage and brand safety risks. To learn more contact info@creopoint.ai


JC Goldenstein
Founder & CEO
+ 1-914-310-4189
CA |  NY | France | Estonia